Fundamental dimension Equity attribute | PAYXLeader $110.75▼-0.79% Cap $39.42BP/E 21.9x QuantScore59/100 | ADPPeer $287.03▼-0.65% Cap $113.7BP/E 26.2x QuantScore45/100 | ASURPeer $7.26▼-1.29% Cap $209.5MP/E -25.2x QuantScore54/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
83/100 |
84/100 |
46/100 |
Valuation Multiples, PEG & DCF upside | 80/100 | 58/100 | 45/100 |
Health Piotroski, Altman Z, leverage & liquidity | 46/100 | 33/100 | 30/100 |
Growth Revenue / earnings growth & margins | 45/100 | 31/100 | 48/100 |
Sentiment Analyst ratings, targets & revisions | 40/100 | 19/100 | 99/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 21.9x | 26.2x | -25.2x |
Forward P/E (next FY) | 18.6x | 23.4x | 8.4x |
EV / EBITDA (TTM) | 14.1x | 17.8x | 9.1x |
Price / Sales | 6.0x | 5.2x | 1.3x |
Price / Free Cash Flow | 19.5x | 22.8x | 19.1x |
PEG ratio | 1.72 | 2.73 | -0.36 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 7 / 9 | 6 / 9 | 5 / 9 |
Altman Z-Score | 3.26 (Safe) | 1.66 (Distress) | -0.16 (Distress) |
Total debt / equity | 1.25 | 0.87 | 0.38 |
Quick ratio | 1.3x | 0.2x | 1.1x |
Interest coverage | 9.7x | 8.9x | -0.2x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +16.9% | +6.7% | +17.3% |
Net income growth YoY | +6.2% | +8.2% | -11.5% |
Gross margin (TTM) | 74.4% | 48.2% | 68.1% |
Operating margin (FY) | 38.6% | 18.6% | -6.0% |
FCF margin (FY) | 35.7% | 23.9% | 15.2% |
5. Trailing price performancePrice change over period |
1M return | -4.6% | +5.8% | -8.2% |
3M return | -3.2% | +12.4% | -3.8% |
6M return | +20.4% | +43.2% | -19.7% |
Year to date | -1.3% | +11.6% | -23.0% |
1Y return | -12.5% | +1.4% | -14.2% |
3Y return | -6.3% | +16.6% | -13.5% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $149.66 +35.1% upside | $292.02 +1.7% upside | $-3.56 -149.0% premium |
Wall Street consensus target | $111.00 +0.2% · range $107.00–$115.00 | $267.67 -6.7% · range $225.00–$310.00 | $14.75 +103.3% · range $11.00–$20.00 |
Consensus stance | 16% Buy68% Hold16% Sell | 22% Buy64% Hold14% Sell | 89% Buy6% Hold6% Sell |